Haemonetics (HAE) Amortization of Deferred Charges (2012 - 2024)
Haemonetics (HAE) posted quarterly Amortization of Deferred Charges of $782000.0 for Q1 2024, down 10.32% year-over-year from $872000.0 in Q1 2023, and little changed quarter-over-quarter from $783000.0 in Q4 2023.
Haemonetics (HAE) Amortization of Deferred Charges (2012 - 2024) Analysis & Trends
Haemonetics' Amortization of Deferred Charges history runs 9 years deep, the most recent figure standing at $782000.0 for Q1 2024.
- In Q1 2024, Amortization of Deferred Charges fell 10.32% year-over-year to $782000.0; the TTM figure through Mar 2024 stood at $3.2 million (up 61.17% YoY), while the FY2024 annual figure was $3.2 million, up 61.17% from the prior year.
- Amortization of Deferred Charges for Q1 2024 stood at $782000.0, roughly flat from $783000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.0 million in Q3 2021, with the low at -$484000.0 in Q4 2022.
- The 5-year median for Amortization of Deferred Charges is $789500.0 (2021), against an average of $630500.0.
- Peak annual rise in Amortization of Deferred Charges reached 472.66% in 2022, while the deepest fall reached 160.96% in 2022.
- Haemonetics' Amortization of Deferred Charges stood at $139000.0 in 2020, then jumped by 471.22% to $794000.0 in 2021, then dropped by 1.13% to $785000.0 in 2022, then dropped by 0.25% to $783000.0 in 2023, then declined by 0.13% to $782000.0 in 2024.
- Business Quant data shows HAE's Amortization of Deferred Charges at $782000.0 in Q1 2024, $783000.0 in Q4 2023, and $780000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2024 | 782,000.00 |
| Mar 30, 2024 | 782,000.00 |
| Dec 30, 2023 | 783,000.00 |
| Dec 30, 2023 | 783,000.00 |
| Sep 30, 2023 | 780,000.00 |
| Sep 30, 2023 | 780,000.00 |
| Jul 1, 2023 | 830,000.00 |
| Jul 1, 2023 | 830,000.00 |
| Apr 1, 2023 | 872,000.00 |
| Apr 1, 2023 | 872,000.00 |
| Dec 31, 2022 | 785,000.00 |
| Dec 31, 2022 | 785,000.00 |
| Oct 1, 2022 | -484,000.00 |
| Oct 1, 2022 | -484,000.00 |
| Jul 2, 2022 | 797,000.00 |
| Jul 2, 2022 | 797,000.00 |
| Apr 2, 2022 | 796,000.00 |
| Apr 2, 2022 | 796,000.00 |
| Jan 1, 2022 | 795,000.00 |
| Jan 1, 2022 | 795,000.00 |